Why Nostr? What is Njump?
2024-07-24 17:37:40
in reply to

npub137…hmn0t on Nostr: 30% profit & $40 a year are, qoute: "based on the costs of lenacapavir’s ...

30% profit & $40 a year are, qoute: "based on the costs of lenacapavir’s ingredients and manufacturing". Not that I'm a fan of the pharma industry fleecing sick people. But I am under the impression that research is a pretty expensive part.
Author Public Key
npub137xdzcqjgvkzhwkzrwj0q69qzugtwcey3edx5y9558ge5dad2huslhmn0t